Dr. Susruthi Rajanala Penumaka , MD
Dermatology β’ Miami, FL
1150 Nw 14th St Ste 503
Miami, FL 331362116
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 31, 2020; this date does not establish years in practice.
-
Published CMS data list 62 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) β 25 prescription fills, including refills.
- Triamcinolone Acetonide β 19 prescription fills, including refills.
- Ketoconazole β 18 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 80% of clinicians listed under Dermatology in Miami, FL (2024, 74 clinicians with data). Median for this group: 345. Middle half: 107 to 681.
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Florida (2024, 913 clinicians with data). Median for this group: 606. Middle half: 256 to 1,130.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 181 in 2022 to 62 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2022β2024.
Practice Location & Contact Primary Location
1150 Nw 14th St Ste 503
Miami, FL 331362116
NPPES lists 1 additional practice-address record in Miami Beach, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: University Of Miami. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2020
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
65 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,224 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $550.70 across 19 records.
By nature of payment
- Food and Beverage: $550.70 across 19 records.
Reporting-company totals (3 largest of 12)
- ABBVIE INC.: $171.05 across 4 records.
- Amgen Inc.: $58.43 across 2 records.
- LEO Pharma Inc.: $57.20 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
6 years (graduated 2020)
CMS Doctors and Clinicians data list 2020 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2020
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Penumaka has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Penumaka as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 80% of clinicians listed under Dermatology in Miami, FL (2024, 74 clinicians with data). Median for this group: 345. Middle half: 107 to 681.
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Florida (2024, 913 clinicians with data). Median for this group: 606. Middle half: 256 to 1,130.
Part D drug cost
A lower Part D drug cost than 80% of clinicians listed under Dermatology in Miami, FL (2024, 74 clinicians with data). Median for this group: $11,546. Middle half: $2,991 to $75,274.
A lower Part D drug cost than 85% of clinicians listed under Dermatology in Florida (2024, 913 clinicians with data). Median for this group: $30,116. Middle half: $5,879 to $163,505.
102 active clinicians are listed under Dermatology with a practice address in Miami, FL (1,225 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
7.8% of these 102 clinicians have the CMS telehealth indicator.
73.5% of these 102 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 66% from 181 in 2022 to 62 in 2024.
- 2022: 181
- 2023: 77
- 2024: 62
-
30-day fills
30-day fills decreased 66% from 192 in 2022 to 65 in 2024.
- 2022: 192
- 2023: 79
- 2024: 65
-
Part D drug cost
Part D drug cost decreased 79% from $10,677 in 2022 to $2,224 in 2024.
- 2022: $10,677
- 2023: $2,214
- 2024: $2,224
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $25.70 in 2021 to $550.70 in 2025.
- 2021: $25.70
- 2022: $643.37
- 2023: $364.44
- 2024: $849.07
- 2025: $550.70
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 19 records totaling $550.70.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
β | General | $115.36 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $29.63 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $29.58 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $28.85 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $28.63 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $28.60 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $28.60 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $27.25 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $27.11 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $26.43 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $26.43 |
| Solta Medical, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
β | General | $24.69 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $23.80 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
β | General | $22.85 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $21.21 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CIBINQO | General | $20.62 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $18.73 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
β | General | $17.55 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $4.78 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 25 | 770 | $1,617.15 | β |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 540 | $270.24 | β |
| Ketoconazole | Ketoconazole | 18 | 510 | $336.47 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-12-19NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20251204001624
FL
8820417124
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Miami
1611 Nw 12 Ave, Miami, FL 331361005
Phone: 3052433100
Secondary Practice Locations
1045 5th St Ste 305
Miami Beach, FL 331396546
Phone: 3052436704
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse, Nurse Practitioner (Certified)
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.), Master of Public Health
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1150 NW 14TH ST STE 503, MIAMI, FL 331362116 (Tel: 3052436704)
Registered at 1600 NW 10TH AVE # 2023A, MIAMI, FL 331361015 (Tel: 3052434472)
Additional practice office at 1045 5th St Ste 305, Miami Beach, FL 331396546
Recorded as SUSRUTHI PENUMAKA, MD
Dermatology (license number reported to NPPES: FL ME176501)
Registered at 1 BOSTON MEDICAL CTR PL, BOSTON, MA 021182908 (Tel: 6176387420)
Registered at 1 BOSTON MEDICAL CTR PL, BOSTON, MA 021182908 (Tel: 6176387420)
Internal Medicine (license number reported to NPPES: MA 283906)
NPI status registered as active in NPPES database
Registered at 2014 WASHINGTON ST, NEWTON, MA 024621699 (Tel: 6172436467)
Registered at 2014 WASHINGTON ST, NEWTON, MA 024621699 (Tel: 6172436467)
Recorded as SUSRUTHI RAJANALA, MD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Miami
- Dr. Tali Czarnowicki, MD
- Dr. Kenneth Rosen, MD
- Dr. Kayla Fourzali, MD, MS
- Dr. Mariya Miteva, MD
- Dr. Lucy Martin, MD
- Dr. Sorrel Resnik, MD
Mailing Address
1600 Nw 10th Ave # 2023a
Miami, FL 331361015
Phone: 3052434472